GP-Act III Acquisition Corp. (GPAT) P/E Ratio History
UndervaluedTrading at 27.0x vs 5Y avg 35.7x · 0th percentile · Below historical baseline · Data 2024–2026
Loading P/E history...
P/E Ratio Analysis
As of July 8, 2026, GP-Act III Acquisition Corp. (GPAT) trades at a price-to-earnings ratio of 27.0x, with a stock price of $11.07 and trailing twelve-month earnings per share of $0.39.
The current P/E is 24% below its 5-year average of 35.7x. Over the past five years, GPAT's P/E has ranged from a low of 29.2x to a high of 56.6x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Financial Services sector median P/E of 14.3x, GPAT trades at a 89% premium to its sector peers. The sector includes 800 companies with P/E ratios ranging from 0.0x to 157.0x.
Relative to the broader market, GPAT trades roughly in line with the S&P 500 median P/E of 25.9x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our GPAT DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
GPAT Cross-Benchmark Valuation
How does the current P/E compare to sector peers and the broader market?
GPAT P/E vs Peers
Generalist SPACs and blank checks peers sorted by market cap
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $558M | 5.4Lowest | - | +41%Best | |
| $321B | 20.3 | 1.29 | +27% | |
| $350B | 21.8 | 2.28 | +28% | |
| $909B | 16.9 | 0.96Best | +2% | |
| $95B | 31.2 | 1.49 | +7% | |
| $85B | 40.7 | - | -29% | |
| $23B | 45.5 | - | +0% |
Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.
GPAT Historical P/E Data (2024–2026)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Period End | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2026 Q1 | - | $10.84 | $0.31 | 34.6x | -3% |
| FY2025 Q4 | Dec 31 2025 | $10.69 | $0.33 | 32.0x | -11% |
| FY2025 Q3 | - | $10.60 | $0.35 | 30.6x | -14% |
| FY2025 Q2 | Jun 30 2025 | $10.55 | $0.36 | 29.6x | -17% |
| FY2025 Q1 | Mar 31 2025 | $10.30 | $0.35 | 29.2x | -18% |
| FY2024 Q4 | - | $10.14 | $0.27 | 37.5x | +5% |
| FY2024 Q3 | Sep 30 2024 | $10.08 | $0.18 | 56.6x | +58% |
Average P/E for displayed period: 35.7x
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
2+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
GPAT — Frequently Asked Questions
Quick answers to the most common questions about buying GPAT stock.
What is GPAT's P/E ratio?
GP-Act III Acquisition Corp. (GPAT) trailing twelve-month P/E ratio is 27.0x, based on TTM diluted EPS of $0.39. The 5-year average P/E is 35.7x and the historical range spans 29.2x to 56.6x.
Is GPAT stock overvalued or undervalued?
GPAT trades at 27.0x P/E, below its 5-year average of 35.7x. At the 0th percentile of its historical range (29.2x–56.6x), the stock is priced at a discount to its own history.
Is GPAT stock expensive?
No, GPAT is not expensive on a historical basis. The current P/E of 27.0x is below the 5-year average of 35.7x and sits at the 0th percentile of its valuation range.
What is GPAT's historical P/E range?
Over the past 5 years, GPAT's P/E ratio has ranged from 29.2x to 56.6x, with a median of 32.0x and an average of 35.7x. The current P/E of 27.0x places the stock at the 0th percentile of this range. Full historical data spans 2024–2026.
How does GPAT's P/E compare to the S&P 500?
GPAT trades at 27.0x P/E versus the S&P 500 median of 25.9x. The 4% premium to the market typically reflects higher expected earnings growth or quality.
How does GPAT's valuation compare to Financial Services peers?
GP-Act III Acquisition Corp. P/E of 27.0x compares to the Financial Services sector median of 14.3x. The premium reflects expected growth above peers or stronger fundamentals. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.
What is GPAT's PEG ratio?
GPAT PEG ratio is N/A, based on a P/E of 27.0x and EPS growth of -12.8%. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.
What is GPAT's earnings yield?
GPAT earnings yield is 3.70%, the inverse of its 27.0x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.